Download PDF
CC BY-NC-ND 4.0 · Yearb Med Inform 2023; 32(01): 146-151
DOI: 10.1055/s-0043-1768748
Section 4: Clinical Research Informatics
Synopsis

Clinical Research Informatics: Contributions from 2022

Xavier Tannier
1   Sorbonne University, Inserm, University Sorbonne Paris-Nord, INSERM UMR_S 1142, LIMICS, F-75006 Paris, France
,
Dipak Kalra
2   The University of Gent, Gent, Belgium
,
Section Editors for the IMIA Yearbook Section on Clinical Research Informatics › Author Affiliations
› Further Information
   Permissions and Reprints

Summary

Objectives: To summarize key contributions to current research in the field of Clinical Research Informatics (CRI) and to select best papers published in 2022.

Method: A bibliographic search using a combination of Medical Subject Headings (MeSH) descriptors and free-text terms on CRI was performed using PubMed, followed by a double-blind review in order to select a list of candidate best papers to be then peer-reviewed by external reviewers. After peer-review ranking, a consensus meeting between the two section editors and the editorial team was organized to finally conclude on the selected three best papers.

Results: Among the 1,324 papers returned by the search, published in 2022, that were in the scope of the various areas of CRI, the full review process selected four best papers. The first best paper describes the process undertaken in Germany, under the national Medical Informatics Initiative, to define a process and to gain multi-decision-maker acceptance of broad consent for the reuse of health data for research whilst remaining compliant with the European General Data Protection Regulation. The authors of the second-best paper present a federated architecture for the conduct of clinical trial feasibility queries that utilizes HL7 Fast Healthcare Interoperability Resources and an HL7 standard query representation. The third best paper aligns with the overall theme of this Yearbook, the inclusivity of potential participants in clinical trials, with recommendations to ensure greater equity. The fourth proposes a multi-modal modelling approach for large scale phenotyping from electronic health record information. This year's survey paper has also examined equity, along with data bias, and found that the relevant publications in 2022 have focused almost exclusively on the issue of bias in Artificial Intelligence (AI).

Conclusions: The literature relevant to CRI in 2022 has largely been dominated by publications that seek to maximise the reusability of wide scale and representative electronic health record information for research, either as big data for distributed analysis or as a source of information from which to identify suitable patients accurately and equitably for invitation to participate in clinical trials.

Keywords

Observational studies as Topic - real-world data - real-world evidence generation - consent - phenotyping


Publication History

Article published online:
26 December 2023

© 2023. IMIA and Thieme. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Gruendner J, Deppenwiese N, Folz M, Köhler T. Kroll B, Prokosch HU, et al. The Architecture of a Feasibility Query Portal for Distributed COVID-19 Fast Healthcare Interoperability Resources (FHIR) Patient Data Repositories: Design and Implementation Study. JMIR Med Inform 2022 May 25;10(5):e36709. doi: 10.2196/36709.
    PubMed
  • 2 Mordenti M, Boarini M, D'Alessandro F, Pedrini E, Locatelli M, Sangiorgi L. Remodeling an existing rare disease registry to be used in regulatory context: Lessons learned and recommendations. Front Pharmacol 2022 Sep 23;13:966081. doi: 10.3389/fphar.2022.966081.
    PubMed
  • 3 Muenzen KD, Amendola LM, Kauffman TL, Mittendorf KF, Bensen JT, Chen F, et al. Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience. HGG Adv 2022 May 20;3(3):100120. doi: 10.1016/j.xhgg.2022.100120.
    PubMed
  • 4 Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, et al. CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. BMJ 2022 Aug 29;378:e069048. doi: 10.1136/bmj-2021-069048.
    PubMed
  • 5 Ahuja Y, Zou Y, Verm, A, Buckeridge D, Li Y. MixEHR-Guided: A guided multi-modal topic modeling approach for large-scale automatic phenotyping using the electronic health record. J Biomed Inform 2022 Oct;134:104190. doi: 10.1016/j.jbi.2022.104190.
    PubMed
  • 6 Zenker S, Strech D, Ihrig, K, Jahns R, Müller G, Schickhardt C, et al. Data protection-compliant broad consent for secondary use of health care data and human biosamples for (bio)medical research: Towards a new German national standard. J Biomed Inform 2022 Jul;131:104096. doi: 10.1016/j.jbi.2022.104096.
    PubMed
  • 7 Peters U, Turner B, Alvarez D, Murray M, Sharma A, Mohan S, et al. Considerations for Embedding Inclusive Research Principles in the Design and Execution of Clinical Trials. Ther Innov Regul Sci 2023 Mar;57(2):186-95. doi: 10.1007/s43441-022-00464-3.
    PubMed
  • 8 Incerti D, Bretscher MT, Lin R, Harbron C. A meta-analytic framework to adjust for bias in external control studies. Pharm Stat 2023 Jan;22(1):162-80. doi: 10.1002/pst.2266.
    PubMed
  • 9 Maurud S, Henni SH, Moen A. Health Equity in Clinical Research Informatics. Yearb Med Inform 2023 Jul 6:138-45. doi: 10.1055/s-0043-1768720.
    PubMed
  • 10 Kussel T, Brenner T, Tremper G, Schepers J, Lablans M, Hamacher K. Record linkage based patient intersection cardinality for rare disease studies using Mainzelliste and secure multi-party computation. J Transl Med 2022 Oct 8;20(1):458. doi: 10.1186/s12967-022-03671-6.
    PubMed